ENO2 and small cell carcinoma: - Small, round, hyperchromatic cells with scant cytoplasm - Immunoreactive for neuroendocrine markers (chromogranin, synaptophysin, CD56, neuron-specific enolase) - Often mixed with non-small-cell carcinoma components - High somatic mutational burden driven by APOBEC-mediated mutations